The Immunogenicity to the First Anti-TNF Therapy Determines the Outcome of Switching to a Second Anti-TNF Therapy in Spondyloarthritis Patients
Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar4258
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC